Intelligent Bio Solutions(INBS.US)

Company Encyclopedia
View More
name
Intelligent Bio Solutions
INBS.US
Intelligent Bio Solutions Inc., a medical technology company, focused on developing and delivering non-invasive testing, and screening solutions in Asia Pacific, the United States, the United Kingdom, and internationally. The company operates intelligent fingerprinting drug screening system, a platform to analyze fingerprint sweat analysis to detect drugs abuse; and biosensor platform. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc.
1.389 T
INBS.USMarket value -Rank by Market Cap -/-

Financial Score

31/12/2025 Update
D
Health Care EquipmentIndustry
Industry Ranking146/175
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreE
    • ROE-223.45%E
    • Profit Margin-330.07%E
    • Gross Margin46.62%B
  • Growth ScoreC
    • Revenue YoY3.26%C
    • Net Profit YoY-4.31%C
    • Total Assets YoY-14.39%E
    • Net Assets YoY-42.40%E
  • Cash ScoreC
    • Cash Flow Margin-30.30%D
    • OCF YoY3.26%C
  • Operating ScoreD
    • Turnover0.3D
  • Debt ScoreD
    • Gearing Ratio65.86%D

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Nasdaq Moves Lower; US Crude Oil Inventories Decline Sharply

    U.S. stocks fell mid-session, with the Dow down 0.28%, NASDAQ down 0.26%, and S&P 500 down 0.26%. U.S. crude oil inventories dropped by 1.934 million barrels, exceeding market expectations. Notable stock movements included Anghami Inc. up 50%, Vanda Pharmaceuticals up 32%, and Intelligent Bio Solutions up 102%. Conversely, Corcept Therapeutics fell 52%, FuelCell Energy down 10%, and SMX down 37%. Initial jobless claims decreased to 199,000, below estimates. European and Asian markets showed mixed results, with declines in major indices.

    fidelity·
    US
    INBS
    +182.93%
    US
    ANGH
    +67.24%
    fidelity·
    US
    INBS
    +182.93%
    US
    ANGH
    +67.24%

    12 Health Care Stocks Moving In Wednesday's Intraday Session

    In Wednesday's intraday session, Intelligent Bio Solutions (NASDAQ:INBS) saw a significant gain of 125.2%, reaching $9.23, while Vanda Pharmaceuticals (NASDAQ:VNDA) rose by 28.9% to $9.06. Other gainers included Axsome Therapeutics (NASDAQ:AXSM) up 19.38% and Park Dental Partners (NASDAQ:PARK) up 17.64%. Conversely, Corcept Therapeutics (NASDAQ:CORT) experienced a sharp decline of 50.2% to $34.95, followed by Profusa (NASDAQ:PFSA) down 18.72%. Overall, the session highlighted notable movements in health care stocks, with both significant gainers and losers.

    benzinga_article·
    US
    AXSM
    +23.14%
    US
    VNDA
    +27.10%
    US
    INBS
    +182.93%
    benzinga_article·
    US
    AXSM
    +23.14%
    US
    VNDA
    +27.10%
    US
    INBS
    +182.93%

    Intelligent Bio Solutions partners with Syrma Johari Medtech, boosting global production and gross margin by 20% pre-U.S. launch.

    INBS has formed a partnership with Syrma Johari Medtech, a renowned global medical device engineering and manufacturing organization. This collaboration will enhance INBS' global manufacturing capacity and bolster supply-chain resilience. It is expected to lead to an approximate 20 percentage points increase in gross margin as the company prepares for its planned market entry into the United States.

    Unusual Whales·
    US
    INBS
    +182.93%
    Unusual Whales·
    US
    INBS
    +182.93%

    Intelligent Bio Solutions Announces New Manufacturing Partnership to Strengthen Global Production Capability and Increase Margins | INBS Stock News

    Intelligent Bio Solutions Inc. (INBS) has announced a strategic manufacturing partnership with Syrma Johari MedTech to enhance its global production capabilities and improve gross margins by approximately 20 percentage points. This collaboration aims to scale production of the Intelligent Fingerprinting Drug Screening Reader, with expected annual production cost savings exceeding 40%. Syrma Johari's extensive manufacturing capacity and regulatory compliance will support INBS's expansion plans, particularly as it prepares for U.S. market entry in 2026. The partnership is expected to strengthen INBS's supply chain resilience and operational efficiency.

    StockTitan·
    US
    INBS
    +182.93%
    StockTitan·
    US
    INBS
    +182.93%

    Intelligent Bio Solutions Partners with Vlepis to Expand Non-Invasive Health Monitoring

    Intelligent Bio Solutions Inc. has formed a strategic partnership with Vlepis Pty Ltd to enhance non-invasive health monitoring. This collaboration aims to innovate in consumer health by integrating Vlepis' wearable technologies with Intelligent Bio Solutions' products, expanding into the consumer health market and potentially boosting international sales. The partnership leverages both companies' expertise in research, development, distribution, and regulation.

    Reuters·
    US
    INBS
    +182.93%
    Reuters·
    US
    INBS
    +182.93%
    © 2025 Longbridge｜Disclaimer